A
Amaia Arruabarrena-Aristorena
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 24
Citations - 833
Amaia Arruabarrena-Aristorena is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 11, co-authored 20 publications receiving 571 citations.
Papers
More filters
Journal ArticleDOI
The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.
Verónica Torrano,Lorea Valcarcel-Jimenez,Ana R. Cortazar,Xiaojing Liu,Jelena Urosevic,Mireia Castillo-Martin,Mireia Castillo-Martin,Sonia Fernández-Ruiz,Giampaolo Morciano,Alfredo Caro-Maldonado,Marc Guiu,Patricia Zúñiga-García,Mariona Graupera,Anna Bellmunt,Pahini Pandya,Mar Lorente,Natalia Martín-Martín,James D. Sutherland,Pilar Sanchez-Mosquera,Laura Bozal-Basterra,Amaia Zabala-Letona,Amaia Arruabarrena-Aristorena,Antonio Berenguer,Nieves Embade,Aitziber Ugalde-Olano,Isabel Lacasa-Viscasillas,Ana Loizaga-Iriarte,M. Unda-Urzaiz,Nikolaus Schultz,Ana M. Aransay,Victoria Sanz-Moreno,Rosa Barrio,Guillermo Velasco,Paolo Pinton,Carlos Cordon-Cardo,Jason W. Locasale,Roger R. Gomis,Arkaitz Carracedo,Arkaitz Carracedo +38 more
TL;DR: A signature based on the PGC1α–ERRα pathway exhibited prognostic potential in prostate cancer, thus uncovering the relevance of monitoring and manipulating this pathway for prostate cancer stratification and treatment.
Journal ArticleDOI
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
Amaia Zabala-Letona,Amaia Arruabarrena-Aristorena,Natalia Martín-Martín,Sonia Fernández-Ruiz,James D. Sutherland,Michelle Clasquin,Julen Tomás-Cortázar,Jose Jimenez,Inés Cristina Torres,Phong Quang,Pilar Ximénez-Embún,Ruzica Bago,Aitziber Ugalde-Olano,Ana Loizaga-Iriarte,Isabel Lacasa-Viscasillas,Miguel Unda,Verónica Torrano,Diana Cabrera,Sebastiaan M. Van Liempd,Ylenia Cendon,Elena Castro,Stuart Murray,Ajinkya Revandkar,Andrea Alimonti,Yinan Zhang,Amelia Barnett,Gina Lein,David Pirman,Ana R. Cortazar,Leire Arreal,Ludmila Prudkin,Ianire Astobiza,Lorea Valcarcel-Jimenez,Patricia Zúñiga-García,Itziar Fernández-Domínguez,Marco Piva,Alfredo Caro-Maldonado,Pilar Sanchez-Mosquera,Mireia Castillo-Martin,Mireia Castillo-Martin,Violeta Serra,Violeta Serra,Naiara Beraza,Antonio Gentilella,George Thomas,Mikel Azkargorta,Felix Elortza,Rosa Farràs,David Olmos,Alejo Efeyan,Juan Anguita,Javier Muñoz,Juan M. Falcón-Pérez,Juan M. Falcón-Pérez,Rosa Barrio,Teresa Macarulla,Teresa Macarulla,José M. Mato,María L. Martínez-Chantar,Carlos Cordon-Cardo,Ana M. Aransay,Kevin R Marks,José Baselga,Josep Tabernero,Josep Tabernero,Paolo Nuciforo,Brendan D. Manning,Katya Marjon,Arkaitz Carracedo +68 more
TL;DR: It is shown that mechanistic target of rapamycin complex 1 (mTORC1) regulates polyamine dynamics, a metabolic route that is essential for oncogenicity.
Journal ArticleDOI
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis.
Helena Serra,Iñigo Chivite,Ana Angulo-Urarte,Adriana Soler,James D. Sutherland,Amaia Arruabarrena-Aristorena,Anan Ragab,Radiance Lim,Marcos Malumbres,Marcus Fruttiger,Michael Potente,Manuel Serrano,Àngels Fabra,Francesc Viñals,Oriol Casanovas,Pier Paolo Pandolfi,Anna Bigas,Arkaitz Carracedo,Holger Gerhardt,Mariona Graupera +19 more
TL;DR: It is shown that both the catalytic and non-catalytic APC/C-Fzr1/Cdh1-mediated activities of PTEN are required for stalk cells' proliferative arrest, and a Notch–PTEN signalling axis as an orchestrator of vessel density is defined.
Journal ArticleDOI
Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism
TL;DR: This review enumerate and discuss current views of the regulation and activity of polyamine metabolism in tumor cell biology and describes polyamines as the oil that lubricates the cancer engine because they affect the activity of biological processes.
Journal ArticleDOI
Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer
Felix Royo,Patricia Zúñiga-García,Verónica Torrano,Ana Loizaga,Pilar Sanchez-Mosquera,Aitziber Ugalde-Olano,Esperanza Gonzalez,Ana R. Cortazar,Laura Palomo,Sonia Fernández-Ruiz,Isabel Lacasa-Viscasillas,María Berdasco,James D. Sutherland,Rosa Barrio,Amaia Zabala-Letona,Natalia Martín-Martín,Amaia Arruabarrena-Aristorena,Lorea Valcarcel-Jimenez,Alfredo Caro-Maldonado,Jorge Gonzalez-Tampan,Guido Cachi-Fuentes,Manel Esteller,Ana M. Aransay,Miguel Unda,Juan M. Falcón-Pérez,Arkaitz Carracedo,Arkaitz Carracedo +26 more
TL;DR: It is shown that urinary EV from prostate cancer patients exhibit genuine and differential physical and biological properties compared to benign prostate hyperplasia (BPH) and transcriptomics characterization of uEVs led to define the decreased abundance of Cadherin 3, type 1 (CDH3) transcript in uEV from PCa patients.